http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 10 Aug 2026 10:39:31 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Press+Releases/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html <p>DENVER, Aug. 10, 2026 (GLOBE NEWSWIRE) -- (247mnn.com) — Today's market is being driven by a potent combination of corporate catalysts, clinical readouts and investor anticipation, with <strong>Socket Mobile (NASDAQ: SCKT)</strong> emerging as one of the session's standout movers while biotech names <strong>AbCellera Biologics (NASDAQ: ABCL)</strong>, <strong>Silence Therapeutics (NASDAQ: SLN)</strong> and <strong>NeOnc Technologies (NASDAQ: NTHI)</strong> command attention around major clinical milestones.</p> <p><strong>Socket Mobile: The Breakout Stock with a New Distribution Engine</strong></p> <p><strong>Socket Mobile (NASDAQ: SCKT)</strong> is kicking off the week as one of the market's most explosive small-cap movers after announcing a strategic partnership with <strong>3Eye Technologies</strong>, http://www.streetinsider.com/Globe+Newswire/The+Catalysts+are+Back%3A+Socket+Mobile+Breaks+Out+while+Biotechs+Race+Toward+Major+Milestones/26895935.html Mon, 10 Aug 2026 10:39:31 -0400 ABCL ABCL NTHI NTHI SCKT SCKT SLN SLN http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Press+Releases/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html <p><strong>Issued on behalf of MindWalk Holdings Corp. (Nasdaq: HYFT)</strong></p><p align="left">AUSTIN, Texas, Aug. 10, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=6PG_U1c75vLehmlhO-Bv1jX1ArWZX_ZqgNeG2LKoFAU8pO9p4nQ_sRN3qXbamRuFqPXw_RUbf7xsqzCwkwzmiOvwu-GypDfKGNAMo-YjdH8=" rel="nofollow" target="_blank">Equity Insider</a> <strong>News Commentary</strong> - Most AI applied to drug discovery works from sequence. Two molecules that look alike in their genetic code are treated as related, and two that do not are treated as unrelated. That assumption is convenient and it is frequently wrong, because biology routinely arrives at the same functional outcome through structures that share no obvious sequence similarity. <a href="https://www.globenewswire.com/Tracker?data=nvAsHf58Mtce76-DaNUnR_lltY13LV4MpIiQt3STUmCnoxH9EdpqdaOuw0EiuSy1Vdq7DNSm5z-0b2GxGDvmuWkSPh0xtlmgx9dWmfKROpk=" rel="nofollow" target="_blank">MindWalk Holdings Corp.</a> (Nasdaq: HYFT) has built its entire technology stack around that http://www.streetinsider.com/Globe+Newswire/AI+Found+an+Influenza+Target+That+Survives+Viral+Mutation/26895427.html Mon, 10 Aug 2026 09:10:00 -0400 ABCL AMD HYFT HYFT SDGR TEM